Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Frequently Bought Together Customer Reviews Based on 0 reviews No reviews yet
DSIP and Withdrawal, Addiction DSIP research noted improvement in animal research models of withdrawal during ethanol and opiate detoxification
Complete Technical Specifications Educational Insights: Understanding GHK-Cu Identity and Quality Why the copper matters GHK alone and GHK-Cu are not interchangeable analytical labels
US$ 28.87
US$ 22.42
US$ 22.55
US$ 26.96
US$ 24.98
US$ 23.57
US$ 28.30
